Clovis Oncology Inc (CLVS) 100.40 $CLVS
Midday Gainer / Losers
Seeking Alpha - at Seeking Alpha - Thu May 14, 11:45AM CDT
KNDI: 9.07 (-1.49), INVE: 7.33 (-1.57), JONE: 9.81 (-1.54), QKLS: 3.10 (+0.83), HIIQ: 5.86 (-1.89), NYMX: 1.71 (+0.03), EGAN: 3.63 (+0.39), GEVO: 3.90 (-0.57), HNR: 1.20 (+0.10), FES: 1.64 (+0.30), ONTY: 2.02 (+0.54), GLPG: 50.50 (+50.50), OHGI: 1.99 (-0.64), ATOS: 1.61 (+0.21), CLVS: 100.40 (+14.40), PSTR: 2.97 (-0.49), AKER: 4.20 (-0.47), RVNC: 24.29 (+4.00), GIGA: 2.10 (-0.73), DSCO: 0.92 (-0.23)
Clovis Oncology Announces Data Presentations at 2015 ASCO Annual Meeting
Business Wire - Wed May 13, 4:01PM CDT
--Rucaparib oral presentation on Monday, June 1 to include outcomes data from full ARIEL2 part one population of ~200 women with advanced ovarian cancer
CLVS: 100.40 (+14.40)
Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
at The Street - Wed May 13, 4:00PM CDT
The American Society of Clinical Oncology has provided public access to 5,000 cancer drug trial research abstracts ahead of its big annual meeting. These will be some highlights for investors.
HALO: 16.31 (+0.05), CLVS: 100.40 (+14.40), CLDX: 25.75 (-0.28), NLNK: 38.12 (-0.17), ONTY: 2.02 (+0.54), PBYI: 170.67 (-39.05), KPTI: 26.83 (-2.51), CELG: 115.08 (+1.68)
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed May 06, 9:48PM CDT
CLVS: 100.40 (+14.40)
Clovis reports 1Q loss
Automated Insights - Wed May 06, 4:58PM CDT
BOULDER, Colo. (AP) _ Clovis Oncology Inc. (CLVS) on Wednesday reported a loss of $63.1 million in its first quarter.
CLVS: 100.40 (+14.40)
Clovis Oncology misses by $0.04
Seeking Alpha - at Seeking Alpha - Wed May 06, 3:10PM CDT
CLVS: 100.40 (+14.40)
Clovis Oncology Announces First Quarter 2015 Operating Results
Business Wire - Wed May 06, 3:01PM CDT
--Launch planning underway for potential late 2015 U.S. launch of rociletinib
CLVS: 100.40 (+14.40)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue May 05, 4:35PM CDT
CODI: 16.61 (-0.04), EXXI: 3.66 (-0.15), FNGN: 41.34 (+0.44), AUQ: 3.71 (-0.05), BGC: 18.75 (+0.03), CHEF: 19.58 (+0.41), FLTX: 40.10 (-0.04), FOXA: 33.33 (+0.41), ANAC: 64.08 (+0.79), EXTR: 2.59 (unch), CJES: 15.05 (-0.14), CCRN: 10.74 (unch), CSLT: 8.68 (-0.38), ETE: 69.16 (-0.03), CSOD: 30.88 (+0.71), CECO: 4.18 (-0.06), BWC: 33.54 (+0.10), CPE: 8.21 (-0.14), FRSH: 17.53 (unch), FNV: 54.79 (+0.16), CHGG: 8.22 (-0.37), CPA: 91.74 (+0.21), ESS: 224.64 (+5.11), EPAM: 66.33 (+0.57), CKP: 10.46 (+0.17), ENSG: 44.39 (+0.36), ACAS: 14.45 (+0.05), CLR: 45.16 (-1.57), GUID: 6.60 (+0.43), ECR: 6.79 (+0.24), GMCR: 103.07 (+0.94), BREW: 10.32 (+0.14), BNFT: 34.36 (-0.41), AWK: 52.99 (+0.76), H: 58.95 (+0.63), CZR: 10.40 (-0.27), GBDC: 16.96 (+0.16), EQC: 26.22 (+0.37), AREX: 7.45 (-0.28), ATML: 8.70 (+0.23), ATVI: 25.17 (+0.54), ETP: 57.35 (+0.66), EGN: 69.51 (+0.35), ALB: 63.63 (+1.09), DMD: 5.10 (-0.09), DPM: 38.35 (+0.34), CUZ: 9.92 (+0.18), EPM: 6.83 (-0.01), ATO: 53.40 (+0.90), CF: 304.29 (-1.05), ALDW: 21.62 (-0.39), CLVS: 100.40 (+14.40), CXW: 35.04 (+0.76), BEAT: 9.83 (+0.15), EFC: 20.19 (+0.08), BRKR: 21.17 (+0.29), AMTG: 15.74 (+0.13)
Next Week In Biotech: Earnings Deluge - From GSK And Achillion To Intercept And Vivus
SA Editor Mike Taylor - Seeking Alpha - Fri May 01, 8:00AM CDT
After this past week's reports from Gilead (NASDAQ: GILD ), Celgene (NASDAQ: CELG ), and other industry heavyweights, we can gear up for another large serving of quarterly reports next week. (Check out SA's Earnings Center for comprehensive...
CYNO: 35.37 (+0.36), AMRN: 1.90 (+0.04), AERI: 11.25 (-0.10), ALXA: 1.15 (unch), INSY: 58.83 (+1.27), KBIO: 0.48 (-0.01), ALNY: 115.87 (+1.48), HZNP: 28.40 (+0.24), AMAG: 61.21 (+1.00), MD: 70.40 (+0.78), ACRX: 3.25 (+0.24), AKRX: 41.58 (+0.16), CBMX: 1.75 (+0.04), GSK: 44.99 (+0.46), ENTA: 37.80 (+1.38), KERX: 10.22 (+0.04), ANIP: 51.57 (+0.26), AVEO: 1.23 (-0.03), HART: 2.65 (+0.04), ICPT: 307.07 (+8.47), FPRX: 21.17 (+0.17), BDSI: 8.72 (+0.38), DVAX: 20.40 (+0.25), ABMD: 68.31 (+2.06), BCRX: 10.55 (+0.25), BSTC: 38.64 (-0.25), BOTA: 2.21 (+0.02), AEGR: 20.42 (+0.39), CTIC: 1.76 (+0.01), ACUR: 0.77 (-0.04), HPTX: 45.99 (+0.02), ACAD: 39.05 (+0.13), HRTX: 12.69 (+0.62), GALE: 1.36 (+0.02), INFI: 12.25 (-0.22), IMMU: 4.07 (-0.06), CERU: 6.06 (-0.23), CNAT: 5.79 (+0.06), EXAS: 23.01 (+0.12), GHDX: 28.11 (+0.24), ALDR: 35.49 (+1.11), ISIS: 62.45 (+1.61), CLVS: 100.40 (+14.40), BIO: 144.13 (-0.37), ACHN: 9.52 (+0.07), BEAT: 9.83 (+0.15), AGIO: 113.47 (+0.19), ARIA: 8.91 (+0.02), ATRS: 2.17 (+0.01), FOLD: 10.50 (+0.04), KPTI: 26.83 (-2.51), ARRY: 7.20 (-0.01)
5 Biotech Stocks to Avoid After Monday's Slump - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 28, 12:33PM CDT
The U.S. stock market was down with the biotech stocks weighing heavily leading to a decline in the in the NASDAQ Biotechnology Index.
BIIB: 394.35 (+4.31), AMGN: 161.98 (+3.59), CLDN: 2.35 (-0.05), ALKS: 60.00 (+1.49), HSP: 88.18 (+0.08), ARGS: 7.59 (-0.08), ESRX: 87.46 (+1.68), GILD: 108.74 (+2.35), CLVS: 100.40 (+14.40), KYTH: 46.65 (unch), ABBV: 65.97 (+0.67), ARNA: 4.25 (-0.05), NVS: 103.90 (+1.23)
Clovis Oncology to Announce First Quarter 2015 Financial Results and Host Webcast Conference Call on May 6
Business Wire - Thu Apr 23, 3:01PM CDT
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2015 financial results on Wednesday, May 6, 2015, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company's results in greater detail.
CLVS: 100.40 (+14.40)
Clovis Oncology (CLVS) Falls: Stock Goes Down 5.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 7:36AM CDT
Clovis Oncology fell over 5% in the last trading session, reversing its recent trend
BIIB: 394.35 (+4.31), CLVS: 100.40 (+14.40)
Where Are The Investors Headed: Complementary Research on Clovis Oncology, DBV Technologies, Cleveland BioLabs, Arrowhead Research and Athenahealth
PR Newswire - Fri Apr 17, 7:25AM CDT
Editor Note: For more information about this release, please scroll to bottom.
DBVT: 25.52 (-0.20), ARWR: 6.31 (+0.14), CLVS: 100.40 (+14.40), CBLI: 1.99 (+0.04), ATHN: 120.02 (+0.22)
Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Wed Apr 15, 12:32PM CDT
ICEL: 16.55 (+0.03), ARWR: 6.31 (+0.14), CLVS: 100.40 (+14.40), UNH: 118.53 (+2.67), ABBV: 65.97 (+0.67), NUVA: 46.01 (+0.54)
Nasdaq stocks posting largest percentage increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
HTBX: 6.17 (+0.27), DOVR: 8.47 (+0.02), STCK: 18.74 (+0.68), CLVS: 100.40 (+14.40), ORMP: 6.44 (-0.05), BIND: 6.24 (+0.07), EGRX: 61.23 (+1.23), VLTC: 8.82 (-0.02), BCLI: 3.70 (-0.08), REPH: 9.67 (-0.51)
Critical Alerts For JP Morgan Chase, Builders FirstSource, Netflix, Clovis Oncology and Ruby Tuesday Released By InvestorsObserver
PR Newswire - Tue Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for JPM, BLDR, NFLX, CLVS and RT.
NFLX: 586.85 (+6.74), RT: 6.90 (+0.09), JPM: 66.05 (+0.53), CLVS: 100.40 (+14.40), BLDR: 12.79 (+0.26)
Clovis Technology Gets Big Boost From Goldman Upgrade
at Investor's Business Daily - Mon Apr 13, 3:06PM CDT
Clovis Technology (CLVS) stock rose Monday after Goldman Sachs upgraded its rating and sharply raised its stock price target on the developer of anti-cancer treatments. Goldman upgraded Clovis to a buy from neutral and increased the price target to...
CLVS: 100.40 (+14.40)
Why Clovis Oncology, Inc. Is Soaring Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Mon Apr 13, 11:26AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Clovis Oncology rallied by...
CLVS: 100.40 (+14.40)
Clovis Oncology heads north on Goldman's higher price target
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 11:18AM CDT
CLVS: 100.40 (+14.40)
Midday Gainer / Losers
Seeking Alpha - at Seeking Alpha - Thu May 14, 11:45AM CDT
KNDI: 9.07 (-1.49), INVE: 7.33 (-1.57), JONE: 9.81 (-1.54), QKLS: 3.10 (+0.83), HIIQ: 5.86 (-1.89), NYMX: 1.71 (+0.03), EGAN: 3.63 (+0.39), GEVO: 3.90 (-0.57), HNR: 1.20 (+0.10), FES: 1.64 (+0.30), ONTY: 2.02 (+0.54), GLPG: 50.50 (+50.50), OHGI: 1.99 (-0.64), ATOS: 1.61 (+0.21), CLVS: 100.40 (+14.40), PSTR: 2.97 (-0.49), AKER: 4.20 (-0.47), RVNC: 24.29 (+4.00), GIGA: 2.10 (-0.73), DSCO: 0.92 (-0.23)
Clovis Oncology Announces Data Presentations at 2015 ASCO Annual Meeting
Business Wire - Wed May 13, 4:01PM CDT
--Rucaparib oral presentation on Monday, June 1 to include outcomes data from full ARIEL2 part one population of ~200 women with advanced ovarian cancer
CLVS: 100.40 (+14.40)
Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
at The Street - Wed May 13, 4:00PM CDT
The American Society of Clinical Oncology has provided public access to 5,000 cancer drug trial research abstracts ahead of its big annual meeting. These will be some highlights for investors.
HALO: 16.31 (+0.05), CLVS: 100.40 (+14.40), CLDX: 25.75 (-0.28), NLNK: 38.12 (-0.17), ONTY: 2.02 (+0.54), PBYI: 170.67 (-39.05), KPTI: 26.83 (-2.51), CELG: 115.08 (+1.68)
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed May 06, 9:48PM CDT
CLVS: 100.40 (+14.40)
Clovis reports 1Q loss
Automated Insights - Wed May 06, 4:58PM CDT
BOULDER, Colo. (AP) _ Clovis Oncology Inc. (CLVS) on Wednesday reported a loss of $63.1 million in its first quarter.
CLVS: 100.40 (+14.40)
Clovis Oncology misses by $0.04
Seeking Alpha - at Seeking Alpha - Wed May 06, 3:10PM CDT
CLVS: 100.40 (+14.40)
Clovis Oncology Announces First Quarter 2015 Operating Results
Business Wire - Wed May 06, 3:01PM CDT
--Launch planning underway for potential late 2015 U.S. launch of rociletinib
CLVS: 100.40 (+14.40)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue May 05, 4:35PM CDT
CODI: 16.61 (-0.04), EXXI: 3.66 (-0.15), FNGN: 41.34 (+0.44), AUQ: 3.71 (-0.05), BGC: 18.75 (+0.03), CHEF: 19.58 (+0.41), FLTX: 40.10 (-0.04), FOXA: 33.33 (+0.41), ANAC: 64.08 (+0.79), EXTR: 2.59 (unch), CJES: 15.05 (-0.14), CCRN: 10.74 (unch), CSLT: 8.68 (-0.38), ETE: 69.16 (-0.03), CSOD: 30.88 (+0.71), CECO: 4.18 (-0.06), BWC: 33.54 (+0.10), CPE: 8.21 (-0.14), FRSH: 17.53 (unch), FNV: 54.79 (+0.16), CHGG: 8.22 (-0.37), CPA: 91.74 (+0.21), ESS: 224.64 (+5.11), EPAM: 66.33 (+0.57), CKP: 10.46 (+0.17), ENSG: 44.39 (+0.36), ACAS: 14.45 (+0.05), CLR: 45.16 (-1.57), GUID: 6.60 (+0.43), ECR: 6.79 (+0.24), GMCR: 103.07 (+0.94), BREW: 10.32 (+0.14), BNFT: 34.36 (-0.41), AWK: 52.99 (+0.76), H: 58.95 (+0.63), CZR: 10.40 (-0.27), GBDC: 16.96 (+0.16), EQC: 26.22 (+0.37), AREX: 7.45 (-0.28), ATML: 8.70 (+0.23), ATVI: 25.17 (+0.54), ETP: 57.35 (+0.66), EGN: 69.51 (+0.35), ALB: 63.63 (+1.09), DMD: 5.10 (-0.09), DPM: 38.35 (+0.34), CUZ: 9.92 (+0.18), EPM: 6.83 (-0.01), ATO: 53.40 (+0.90), CF: 304.29 (-1.05), ALDW: 21.62 (-0.39), CLVS: 100.40 (+14.40), CXW: 35.04 (+0.76), BEAT: 9.83 (+0.15), EFC: 20.19 (+0.08), BRKR: 21.17 (+0.29), AMTG: 15.74 (+0.13)
Next Week In Biotech: Earnings Deluge - From GSK And Achillion To Intercept And Vivus
SA Editor Mike Taylor - Seeking Alpha - Fri May 01, 8:00AM CDT
After this past week's reports from Gilead (NASDAQ: GILD ), Celgene (NASDAQ: CELG ), and other industry heavyweights, we can gear up for another large serving of quarterly reports next week. (Check out SA's Earnings Center for comprehensive...
CYNO: 35.37 (+0.36), AMRN: 1.90 (+0.04), AERI: 11.25 (-0.10), ALXA: 1.15 (unch), INSY: 58.83 (+1.27), KBIO: 0.48 (-0.01), ALNY: 115.87 (+1.48), HZNP: 28.40 (+0.24), AMAG: 61.21 (+1.00), MD: 70.40 (+0.78), ACRX: 3.25 (+0.24), AKRX: 41.58 (+0.16), CBMX: 1.75 (+0.04), GSK: 44.99 (+0.46), ENTA: 37.80 (+1.38), KERX: 10.22 (+0.04), ANIP: 51.57 (+0.26), AVEO: 1.23 (-0.03), HART: 2.65 (+0.04), ICPT: 307.07 (+8.47), FPRX: 21.17 (+0.17), BDSI: 8.72 (+0.38), DVAX: 20.40 (+0.25), ABMD: 68.31 (+2.06), BCRX: 10.55 (+0.25), BSTC: 38.64 (-0.25), BOTA: 2.21 (+0.02), AEGR: 20.42 (+0.39), CTIC: 1.76 (+0.01), ACUR: 0.77 (-0.04), HPTX: 45.99 (+0.02), ACAD: 39.05 (+0.13), HRTX: 12.69 (+0.62), GALE: 1.36 (+0.02), INFI: 12.25 (-0.22), IMMU: 4.07 (-0.06), CERU: 6.06 (-0.23), CNAT: 5.79 (+0.06), EXAS: 23.01 (+0.12), GHDX: 28.11 (+0.24), ALDR: 35.49 (+1.11), ISIS: 62.45 (+1.61), CLVS: 100.40 (+14.40), BIO: 144.13 (-0.37), ACHN: 9.52 (+0.07), BEAT: 9.83 (+0.15), AGIO: 113.47 (+0.19), ARIA: 8.91 (+0.02), ATRS: 2.17 (+0.01), FOLD: 10.50 (+0.04), KPTI: 26.83 (-2.51), ARRY: 7.20 (-0.01)
5 Biotech Stocks to Avoid After Monday's Slump - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 28, 12:33PM CDT
The U.S. stock market was down with the biotech stocks weighing heavily leading to a decline in the in the NASDAQ Biotechnology Index.
BIIB: 394.35 (+4.31), AMGN: 161.98 (+3.59), CLDN: 2.35 (-0.05), ALKS: 60.00 (+1.49), HSP: 88.18 (+0.08), ARGS: 7.59 (-0.08), ESRX: 87.46 (+1.68), GILD: 108.74 (+2.35), CLVS: 100.40 (+14.40), KYTH: 46.65 (unch), ABBV: 65.97 (+0.67), ARNA: 4.25 (-0.05), NVS: 103.90 (+1.23)
Clovis Oncology to Announce First Quarter 2015 Financial Results and Host Webcast Conference Call on May 6
Business Wire - Thu Apr 23, 3:01PM CDT
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2015 financial results on Wednesday, May 6, 2015, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company's results in greater detail.
CLVS: 100.40 (+14.40)
Clovis Oncology (CLVS) Falls: Stock Goes Down 5.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 7:36AM CDT
Clovis Oncology fell over 5% in the last trading session, reversing its recent trend
BIIB: 394.35 (+4.31), CLVS: 100.40 (+14.40)
Where Are The Investors Headed: Complementary Research on Clovis Oncology, DBV Technologies, Cleveland BioLabs, Arrowhead Research and Athenahealth
PR Newswire - Fri Apr 17, 7:25AM CDT
Editor Note: For more information about this release, please scroll to bottom.
DBVT: 25.52 (-0.20), ARWR: 6.31 (+0.14), CLVS: 100.40 (+14.40), CBLI: 1.99 (+0.04), ATHN: 120.02 (+0.22)
Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Wed Apr 15, 12:32PM CDT
ICEL: 16.55 (+0.03), ARWR: 6.31 (+0.14), CLVS: 100.40 (+14.40), UNH: 118.53 (+2.67), ABBV: 65.97 (+0.67), NUVA: 46.01 (+0.54)
Nasdaq stocks posting largest percentage increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
HTBX: 6.17 (+0.27), DOVR: 8.47 (+0.02), STCK: 18.74 (+0.68), CLVS: 100.40 (+14.40), ORMP: 6.44 (-0.05), BIND: 6.24 (+0.07), EGRX: 61.23 (+1.23), VLTC: 8.82 (-0.02), BCLI: 3.70 (-0.08), REPH: 9.67 (-0.51)
Critical Alerts For JP Morgan Chase, Builders FirstSource, Netflix, Clovis Oncology and Ruby Tuesday Released By InvestorsObserver
PR Newswire - Tue Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for JPM, BLDR, NFLX, CLVS and RT.
NFLX: 586.85 (+6.74), RT: 6.90 (+0.09), JPM: 66.05 (+0.53), CLVS: 100.40 (+14.40), BLDR: 12.79 (+0.26)
Clovis Technology Gets Big Boost From Goldman Upgrade
at Investor's Business Daily - Mon Apr 13, 3:06PM CDT
Clovis Technology (CLVS) stock rose Monday after Goldman Sachs upgraded its rating and sharply raised its stock price target on the developer of anti-cancer treatments. Goldman upgraded Clovis to a buy from neutral and increased the price target to...
CLVS: 100.40 (+14.40)
Why Clovis Oncology, Inc. Is Soaring Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Mon Apr 13, 11:26AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Clovis Oncology rallied by...
CLVS: 100.40 (+14.40)
Clovis Oncology heads north on Goldman's higher price target
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 11:18AM CDT
CLVS: 100.40 (+14.40)
